Peer review reports
From: SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
| Original Submission |
| 3 Oct 2011 |
Submitted |
Original manuscript
|
| 10 Oct 2011 |
Author responded |
Author comments - Chris Hurt
|
| Resubmission - Version 2 |
| 10 Oct 2011 |
Submitted |
Manuscript version 2
|
| Publishing |
| 28 Oct 2011 |
Editorially accepted |
|
| 28 Oct 2011 |
Article published |
10.1186/1471-2407-11-466
|
Learn about peer review
